FDA Adverse Event Other Summary report: N

V.A.C. (VACUUM ASSISTED CLOSURE)

MDR report key: 413700 · Received August 26, 2002

Report

Report Number
MW1025997
Event Type
Other
Date Received
August 26, 2002
Date of Event
July 25, 2002
Report Date
August 23, 2002
Manufacturer
KCI
Product Code
GCY
Report Source
Voluntary report
Reporter Location
CA, US
Reporter Occupation
RISK MANAGER

Narratives

Description of Event or Problem · 1

DURING SURGICAL PROCEDURE FOR POSTOP WOUND INFECTION IDENTIFIED AS BLACK KCI WOUND V.A.C. SPONGE THAT HAD BEEN RETAINED FOR AN UNDETERMINED PERIOD OF TIME.

Description of Event or Problem · 1

ADD'L INFO RECEIVED FROM MFR 11-22-02: IN THE COURSE OF THE INVESTIGATION, KCI REVIEWED THE PT'S V.A.C. PLACEMENT HISTORY AND DETERMINED THE PT RECEIVED V.A.C. THERAPY FROM MARCH 2002 THROUGH APRIL 2002 AT WHICH TIME THE V.A.C. SYSTEM WAS DISCONTINUED AND THE PT WAS DISCHARGED TO AN EXTENDED CARE FACILITY. IT IS ESTIMATED THAT THE PT WAS READMITTED TO THE REPORTING FACILITY SOMETIME IN MID-JUNE. IN THE REPORTED INCIDENT, ONE OF THE PIECES THAT HAD BEEN INSERTED FOR V.A.C. THERAPY HAD REPORTEDLY NOT BEEN REMOVED WHEN THERAPY WAS DISCONTINUED. ALL MEDICAL PROFESSIONALS ARE AWARE OF THE BASIC MEDICAL STANDARD OF CARE GUIDELINES. THE GUIDELINES INCLUDE PRECAUTIONS TO COUNT AND RECORD THE NUMBER OF PIECES INSERTED IN A WOUND AND/OR BODY CAVITY AND TO ACCOUNT FOR EACH PIECE WHEN REMOVED. THE KCI CORPORATE REP INVESTIGATING THE MATTER HAS ASKED THE FACILITY PERSONNEL FOR MORE INFO TO FACILITATE KCI'S INVESTIGATION. HOWEVER, SUCH PERSONNEL AT THE FACILITY HAVE NOT BEEN WILLING TO PROVIDE ANY ADD'L INFO AT THIS TIME. THE BLACK POLYURETHANE FOAM DRESSING IS COMPOSED OF A POLYURETHANE MATERIAL, PACKAGED STERILE FOR SINGLE USE ONLY AND AVAILABLE IN SMALL, MEDIUM AND LARGE SIZES. THERE IS NO EVIDENCE OR INFO THAT SUGGESTS THE FOAM DRESSING INTRODUCED THE INFECTION INVOLVED IN THIS REPORT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 V.A.C. (VACUUM ASSISTED CLOSURE) WOUND CLOSURE GCY KCI * *

Patients

Seq Age Sex Outcome Treatment
1 62 YR Other